This can be a short description about this vertical and all the great links contained therein.
R&D Strategy
Evidence
Pipeline
Clinical Trials
Article originally published February 2026 […]
Learn More ›
This can be a short description about this vertical and all the great links contained therein.
First-ever FDA authorized AI sepsis diagnostic tool with powerful diagnostic and predictive capabilities
5th World Sepsis Congress | […]
Learn More ›
This can be a short description about this vertical and all the great links contained therein.
Resource Library
Events
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Mission, Vision, Values
Careers
Leadership
Awards
AI in Chicago | Episode […]
Learn More ›
Release originally posted on HIT Consultant
The Chicago-based health tech company Prenosis revealed a dual milestone: the closing of a $20M Series A financing round and the awarding of a $20M contract from the Biomedical Advanced Research and Development Authority (BARDA). This combined $40M war chest positions Prenosis to move beyond simple diagnostics and into the realm of “precision critical care.”
Read full release >